The relationship between intestinal parasites and some immune-mediated intestinal conditions

Gastroenterology and Hepatology from Bed to Bench

Volumn 8, Issue 2, 2015, Pages 123-131

  Mohammadi, Rasoul ^a   Hosseini Safa, Ahmad ^b   Ehsani Ardakani, Mohammad Javad ^c   Rostami Nejad, Mohammad ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Celiac disease; Inflammatory bowel diseases; Intestinal parasites; Irritable bowel syndrome

Indexed keywords

BLASTOCYSTOSIS; CELIAC DISEASE; CROHN DISEASE; CYTOKINE PRODUCTION; DIENTAMOEBIASIS; DYSPEPSIA; GIARDIASIS; HAPLORCHIS TAICHUI; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE NECROSIS; INTESTINE PARASITE; INTESTINE VILLUS ATROPHY; IRRITABLE COLON; MALABSORPTION; NECATOR AMERICANUS; NONHUMAN; REVIEW; STRONGYLOIDIASIS; TOXOPLASMOSIS; TREMATODE; TRICHINOSIS; TRICHURIASIS; ULCERATIVE COLITIS;

EID: 84928952344     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005;5:420-26.
2. Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med 2002;139:334-38.
3. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
4. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
5. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357:1731-43.
6. Bhatnagar S, Tandon N. Diagnosis of celiac disease. Indian J Pediatr 2006;73:703-709.
7. Endo K, Shiga H, Kinouchi Y, Shimosegawa T. [Inflammatory bowel disease: IBD]. Rinsho Byori 2009; 57:527-32.
8. Parray FQ, Wani ML, Malik AA, Wani SN, Bijli AH, Irshad I. Ulcerative colitis: a challenge to surgeons. Int J Prev Med 2012; 3:749.
9. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24:S2-6.
10. van Asseldonk DP, Seinen ML, de Boer NK, van Bodegraven AA, Mulder CJ. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment. J Crohns Colitis 2012;6:95-101.
11. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109:671-80.
12. Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am 2010; 24:961-75.
13. Rodríguez LAG, Ruigómez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999; 318:565-66.
14. Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007; 5:465-69.
15. De Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003; 19:547-51.
16. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, Loukas A. New technologies for the control of human hookworm infection. Trends Parasitol 2006; 22:327-31.
17. McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 2011; 6:e24092.
18. Dave M, Purohit T, Razonable R, Loftus Jr EV. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis 2014; 20:196-212.
19. Ruyssers NE, De Winter BY, De Man JG, Loukas A, Pearson MS, Weinstock JV, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis 2009;15:491-500.
20. Wammes LJ, Mpairwe H, Elliott AM, Yazdanbakhsh M. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. Lancet Infect Dis 2014; 14:1150-62.
21. Gaze S, McSorley HJ, Daveson J, Jones D, Bethony JM, Oliveira LM, et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog 2012; 8:e1002520.
22. Croese J, Gaze ST, Loukas A. Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity. Int J Parasitol 2013; 43:275-82.
23. Fantini MC, Rizzo A, Fina D, Caruso R, Sarra M, Stolfi C, et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 2009; 136:1308-16.
24. Hmida NB, Ahmed MB, Moussa A, Rejeb MB, Said Y, Kourda N, et al. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? Am J Gastroenterol 2011; 107:604-11.
25. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012; 18:6036.
26. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011; 140:1704-12.
27. Slack A. Parasitic causes of prolonged diarrhoea in travelers: Diagnosis and management. Aust Fam Physician 2012; 41:782.
28. Jiménez O, Carbonell A, García O, Rodríguez L, Triana F, Fabián L. Blastocystis hominis in symptomatic celiac patients. Acta Gastroenterol Latinoam 2012; 42:175-81.
29. Fouad SA, Esmat S, Basyoni MM, Farhan MS, Kobaisi MH. Molecular identification of Giardia intestinalis in patients with dyspepsia. Digest 2014; 90:63-71.
30. Behera B, Mirdha B, Makharia GK, Bhatnagar S, Dattagupta S, Samantaray J. Parasites in patients with malabsorption syndrome: a clinical study in children and adults. Dig Dis Sci 2008; 53:672-79.
31. Nejad MR, Rostami K, Cheraghipour K, Mojarad EN, Volta U, Al Dulaimi D, et al. Celiac disease increases the risk of Toxoplasma gondii infection in a large cohort of pregnant women. Am J Gastroenterol 2011; 106:548-49.
32. Lidar M, Lipschitz N, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, et al Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci 2009; 1173:649-57.
33. Elliott DE, Weinstock JV. Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci 2012; 1247:83-96.
34. Ince MN, Elliott DE, Setiawan T, Metwali A, Blum A, Chen Hl, et al. Role of T cell TGF-β signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol 2009; 39:1870-78.
35. Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM, Loddenkemper C, et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 2008; 180:4265-72.
36. Moghadam K, Khashayar P, Hashemi M. Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. Acta Med Indones 2011;43:191-94.
37. Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar FG, Yolcular BO. Blastocystosis in patients with gastrointestinal symptoms: a case-control study. BMC Gastroenterol 2012; 12:122.
38. Satoskar AR, Bozza M, Sosa MR, Lin G, David JR. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 2001; 69:906-11.
39. McDevitt MA, Xie J, Shanmugasundaram G, Griffith J, Liu A, McDonald C, et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 2006; 203:1185-96.
40. Terrazas CA, Juarez I, Terrazas LI, Saavedra R, Calleja EA, Rodriguez-Sosa M. Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection. Exp Parasitol 2010;26:348-58.
41. Cavalcanti MG, Mesquita JS, Madi K, Feijó DF, Assunção-Miranda I, Souza HS, et al. MIF participates in Toxoplasma gondii-induced pathology following oral infection. PLoS One 2011; 6:e25259.
42. Büning J, Homann N, von Smolinski D, Borcherding F, Noack F, Stolte M, et al. Helminths as governors of inflammatory bowel disease. Gut 2008; 57:1182-83.
43. Moreels TG, Pelckmans PA. Gastrointestinal parasites. Potential therapy for refractory inflammatory bowel diseases. Inflamm Bowel Dis 2005; 11:178-84.
44. Weerasekara D, Fernando N, Meedin F, Holton J, Fernando D. Clinical presentation and risk factors of inflammatory bowel disease in Sri Lanka. Trop Gastroenterol 2011; 32:31-35.
45. Elliott DE, Summers RW, Weinstock JV. Helminths as governors of immune-mediated inflammation. Int J Parasitol 2007; 37:457-64.
46. Brunet LR, Dunne D, Pearce E. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 1998; 14:422-27.
47. Motomura Y, Wang H, Deng Y, El-Sharkawy R, Verdu E, Khan W. Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin Exp Immunol 2009; 155:88-95.
48. Khan W, Blennerhasset P, Varghese A, Chowdhury S, Omsted P, Deng Y, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun 2002;70:5931-37.
49. Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban Jr JF, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Renal Physiol 2003; 284:G385-G91.
50. Wang LJ, Cao Y, Shi HN. Helminth infections and intestinal inflammation. World J Gastroenterol 2008; 14:5125.
51. Whelan RA, Hartmann S, Rausch S. Nematode modulation of inflammatory bowel disease. Protoplasma 2012; 249:871-86.
52. Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003; 98:2034-41.
53. Thompson RA, Elliot DE, Urban JF, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128:825-32.
54. Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, et al. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey. PLoS One 2010; 5:e15484.
55. Stark D, Van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007; 37:11-20.
56. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136:1979-88.
57. Morgan DR, Benshoff M, Cáceres M, Becker-Dreps S, Cortes L, Martin CF, et al. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract 2012; 2012: 343812.
58. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja O, EL-Salhy M, et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31:883-91.
59. Borody T, Warren E, Wettstein A, Robertson G, Recabarren P, Fontella A, et al. Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 2002; 17:A103.
60. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107:679-84.
61. Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, et al. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 2012; 110:1269-75.
62. Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. J Trop Med Hyg 2012; 87:1046-52.
63. Chai J-Y, Han E-T, Shin E-H, Sohn W-M, Yong T-S, Eom KS, et al. High prevalence of Haplorchis taichui, Phaneropsolus molenkampi, and other helminth infections among people in Khammouane Province, Lao PDR. Korean J Parasitol 2009; 47:243-47.
64. Kumchoo K, Wongsawad C, Chai J-Y, Vanittanakom P, Rojanapaibul A. High prevalence of Haplorchis taichui metacercariae in cyprinoid fish from Chiang Mai Province, Thailand. Southeast Asian J Trop Med Public Health 2005; 36:451-55.
65. Watthanakulpanich D, Waikagul J, Maipanich W, Nuamtanong S, Sanguankiat S, Pubampen S, et al. Haplorchis taichui as a possible etiologic agent of irritable bowel syndrome-like symptoms. Korean J Parasitol 2010; 48:225-29.
66. Soyturk M, Akpinar H, Gurler O, Pozio E, Sari I, Akar S, et al. Irritable bowel syndrome in persons who acquired trichinellosis. Am J Gastroenterol 2007; 102:1064-9.
67. Diniz-Santos DR, Jambeiro J, Mascarenhas RR, Silva LR. Massive Trichuris trichiura infection as a cause of chronic bloody diarrhea in a child. J Trop Pediatr 2006; 52:66-68.